CRISPR Therapeutics AG Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 4,912 | 61,744 | 8,666 | |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 26,422 | 332,125 | 13,578 | |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 5.86 | 38,666 | 226,583 | 0 | |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.18 | 4,912 | 369,272 | 20,000 | 24.9 K to 20 K (-19.72 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 4,912 | 61,744 | 24,912 | 20 K to 24.9 K (+24.56 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.26 | 2,913 | 222,138 | 20,000 | 22.9 K to 20 K (-12.71 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.32 | 12,175 | 917,054 | 22,913 | 35.1 K to 22.9 K (-34.70 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.50 | 800 | 61,201 | 35,088 | 35.9 K to 35.1 K (-2.23 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.94 | 3,934 | 298,736 | 35,888 | 39.8 K to 35.9 K (-9.88 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 74.90 | 6,600 | 494,323 | 39,822 | 46.4 K to 39.8 K (-14.22 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 26,422 | 332,125 | 46,422 | 20 K to 46.4 K (+132.11 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.50 | 22,700 | 1,736,575 | 20,000 | 42.7 K to 20 K (-53.16 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.93 | 15,966 | 1,212,265 | 42,700 | 58.7 K to 42.7 K (-27.22 %) |
| Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 5.86 | 38,666 | 226,583 | 58,666 | 20 K to 58.7 K (+193.33 %) |
| Jun 25 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 75.00 | 50,000 | 3,750,000 | 698,007 | 748 K to 698 K (-6.68 %) |
| Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 75.35 | 10,000 | 753,453 | 574,190 | 584.2 K to 574.2 K (-1.71 %) |
| Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 72.51 | 10,000 | 725,069 | 584,190 | 594.2 K to 584.2 K (-1.68 %) |
| Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 75.20 | 6,929 | 521,061 | 33,747 | 40.7 K to 33.7 K (-17.03 %) |
| Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 70.14 | 229 | 16,062 | 40,676 | 40.9 K to 40.7 K (-0.56 %) |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Behbahani Ali | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Treco Douglas A | Director | Option Exercise | A | 59.70 | 30,000 | 1,791,000 | 30,000 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | High Katherine A | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Greene John | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 1.81 | 17,275 | 31,268 | 162,783 | |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Payment of Exercise | F | 66.26 | 779 | 51,617 | 170,747 | 171.5 K to 170.7 K (-0.45 %) |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 65.26 | 5,575 | 363,825 | 171,526 | 177.1 K to 171.5 K (-3.15 %) |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 64.61 | 9,300 | 600,873 | 177,101 | 186.4 K to 177.1 K (-4.99 %) |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 63.57 | 2,400 | 152,568 | 186,401 | 188.8 K to 186.4 K (-1.27 %) |
| Jun 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 1.81 | 17,275 | 31,268 | 188,801 | 171.5 K to 188.8 K (+10.07 %) |